Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

被引：0
|
作者：
Hou, Hsin-An
Tang, Chao-Hsiun
Liu, Hung-Yi
Qiu, Hong
Siggins, Sarah
Rothwell, Lee Anne
Yang, Ya-Wen
Pei, Sung-Nan
Zhang, Yongjing
Liu, Yanfang
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5434
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Real-World Treatment Patterns and Outcomes Among Multiple Myeloma Patients with Asthma and COPD in the United States
    Rice, Megan S.
    Naeger, Sarah
    Singh, Erin
    ONCOLOGY AND THERAPY, 2021, 9 (01) : 195 - 212
  • [42] Analysis of real-world (RW) pomalidomide (pom) dosing patterns in patients (pts) with multiple myeloma (MM) from the Flatiron database
    Dhakal, Binod
    Godara, Amandeep
    Medvedova, Eva
    Naik, Seema
    Nooka, Ajay K.
    Parekh, Trilok V.
    Hadley, David
    Kansagra, Ankit J.
    Anderson, Larry D., Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Insurance status and survival of multiple myeloma (MM) patients.
    Chamoun, Kamal
    De Lima, Marcos J. G.
    Caimi, Paolo Fabrizio
    Fu, Pingfu
    Cao, Shufen
    Otegbeye, Folashade
    Patel, Seema
    Ali, Naveed
    Gerson, Stanton L.
    Boughan, Kirsten M.
    Kyasaram, Ravi Kumar
    Malek, Ehsan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (18)
  • [44] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    BLOOD, 2014, 124 (21)
  • [45] Association between race and treatment patterns and survival outcomes in multiple myeloma: A connect MM registry analysis
    Ailawadhi, Sikander
    Jagannath, Sundar
    Lee, Hans C.
    Narang, Mohit
    Rifkin, Robert M.
    Terebelo, Howard R.
    Durie, Brian G. M.
    Toomey, Kathleen
    Hardin, James W.
    Gasparetto, Cristina J.
    Wagner, Lynne
    Omel, James L.
    He, Mia
    Yue, Lihua
    Flick, Elizabeth Dawn
    Agarwal, Amit
    Abonour, Rafat
    CANCER, 2020, 126 (19) : 4332 - 4340
  • [46] Real-World Progression-Free Survival and Treatment Patterns for t(11;14) Positive Patients with Multiple Myeloma with at Least 2 Prior Lines of Treatment
    Girvan, Allicia
    Martins, Daniel
    Yu, Junhua
    Ng, Sophia
    Kamalakar, Rajesh
    Zafar, Faiza
    Tulsian, Seema
    Cornell, Robert F.
    Samir, Mohamed
    BLOOD, 2023, 142
  • [47] The optimal dose of thalidomide on the treatment of newly diagnosed multiple myeloma: real-world experience in Taiwan
    Liao, Po Wei
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S159 - S159
  • [48] Real World Treatment Outcomes of Multiple Myeloma in Korea
    Byun, Ja Min
    Yoon, Sung-Soo
    Shin, Dong-Yeop
    Koh, Youngil
    Kim, Inho
    Kim, Hyun Kyung
    Lee, Dong Soon
    Lee, Jung-Lim
    Kim, Byung Su
    BLOOD, 2016, 128 (22)
  • [49] UPFRONT OVERALL SURVIVAL MODELLING IN COMPARISON TO REAL WORLD DATA: LENALIDOMIDE FOR THE TREATMENT OF MULTIPLE MYELOMA PATIENTS IN SOUTH KOREA
    Felix, J.
    Vandewalle, B.
    Almeida, J.
    Valeska, A.
    VALUE IN HEALTH, 2014, 17 (07) : A729 - A729
  • [50] Real-world treatment patterns and outcomes of triple-class treated patients with multiple myeloma in the United States
    Varughese, Prateesh
    Smith, Robert
    Xue, Mei
    Dorrow, Natalie
    Hogea, Cosmina
    Maiese, Eric. M.
    Buckingham, Trudy
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (01) : 65 - 74
12345